Vaccines

Jeff Balser, MD, PhD, talks about the many challenges VUMC has faced during the past year at this week’s Leadership assembly. (photo by Donn Jones)
February 18, 2021

Take care of you: 5 Takeaways from Leadership Assembly

In the 351 days since the COVID-19 Command Center opened to steer Vanderbilt University Medical Center through the pandemic, the workforce stepped up and contributed, keeping the health system on track to deliver care even as the landscape quaked with new challenges.

By Holly Fletcher
Ken and Kathy Hazelwood are among those who have received treatment at VUMC’s COVID Infusion Clinic.
February 10, 2021

More than 1,000 receive antibody infusions for COVID-19 at VUMC

As of Feb. 1,065 outpatients have received antibody infusions since the clinic opened on Nov. 18. Clinic officials estimated that the infusions have prevented about 70 patients from developing severe COVID-19 illness requiring hospitalization or emergency department evaluation.

By Bill Snyder
January 14, 2021

Vanderbilt Health Employer Solutions pivots during first year

In early 2020, several groups at Vanderbilt University Medical Center were busy planning an in-person event to announce the creation of Vanderbilt Health Employer Solutions, a team designed to provide workforce health and wellness services to businesses of all types and sizes. By March, it was clear that area employers needed a trusted source of information and support to manage the COVID-19 pandemic.

By Jamie Roberts
December 21, 2020

HERO-TOGETHER study seeks health care workers who receive COVID-19 vaccine

Health care workers, who have been disproportionately affected by the COVID-19 pandemic, will be the first tier of Vanderbilt University Medical Center employees to receive vaccine to prevent SARS-CoV-2 infection.

By Kathy Whitney
The “orange team,” led by Buddy Creech, MD, director of the Vanderbilt Vaccine Research Program, assembles in the old Clinical Research Center space in Medical Center North on the first day of the phase 3 Moderna vaccine study this summer.
December 16, 2020

Coronavirus ‘crusaders’ spur VUMC research achievements

The development of the vaccines, monoclonal antibodies and antiviral drugs that ultimately will defeat COVID-19 wouldn’t have been possible had it not been for the unflagging and selfless efforts of a global army of research nurses, laboratory personnel, recruiters and other staff.

By Bill Snyder
December 10, 2020

Exploiting viral vulnerabilities

The isolation of human monoclonal antibodies against dangerous viruses including EEEV, Hendra and Nipah could offer new ways to treat and prevent these infections.

By Bill Snyder